Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE2117.10-32.3 (-1.5 %)
PREV CLOSE () 2149.40
OPEN PRICE () 2151.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8457
TODAY'S LOW / HIGH ()2109.00 2158.00
52 WK LOW / HIGH ()1200.35 2312
NSE2119.85-30.55 (-1.42 %)
PREV CLOSE() 2150.40
OPEN PRICE () 2159.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2119.85 (265)
VOLUME 652699
TODAY'S LOW / HIGH() 2110.60 2159.25
52 WK LOW / HIGH ()1200.15 2312
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
09Dec Lupin informs about disclosures
Lupin has informed that the Exchange has received the disclosure under R..
02Dec Clarification /Confirmation On The Ne
Clarification / confirmation on the news item appearing in www.business-..
26Nov Lupin’s arm recalling over 6 lakh bott
Lupin’s arm -- Lupin Pharmaceuticals Inc. is recalling 6,16,506 bottles..
08Nov Lupin reports 74% rise in Q2 consolida
Lupin has reported results for second quarter ended September 30, 2024 (..
08Nov Lupin inches up on reporting 74% rise
Lupin is currently trading at Rs. 2110.75, up by 0.20 points or 0.01% fr..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit8077.623260.9
Gross Profit 9840.5 27846.9
Operating Profit 11473.735657.9
Net Sales 41062146665
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
 5679.65 (1.62%)
M.Cap ( in Cr)
9427.87
Ajanta Pharma (BSE)
 2840.60 (1.68%)
M.Cap ( in Cr)
35482.53
Astrazeneca Pharma I (BSE)
 6636.00 (0.62%)
M.Cap ( in Cr)
16590.00
Jenburkt Pharma (BSE)
 1325.60 (3.02%)
M.Cap ( in Cr)
585.03
Mankind Pharma (BSE)
 2650.55 (1.05%)
M.Cap ( in Cr)
106197.50
Shareholding Pattern
PROMOTERS 46.96%
MUTUAL FUNDS/UTI 16.89%
FI/BANKS/INSURANCE 7.24%
NON-INSTITUTION 6.44%
GOVERNMENT 0.01%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX81289.96-236.18 (-0.29%)
NIFTY24548.70-93.10 (-0.38%)
Dow Jones 44148.56-99.27 (-0.22%)
Nasdaq 20034.89347.65 (1.77%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI